Pakistan
· Delayed Price · Currency is PKR Sitara Peroxide Statistics
Total Valuation
Sitara Peroxide has a market cap or net worth of PKR 733.93 million. The enterprise value is 1.14 billion.
| Market Cap | 733.93M |
| Enterprise Value | 1.14B |
Important Dates
The last earnings date was Wednesday, October 2, 2024.
| Earnings Date | Oct 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Sitara Peroxide has 55.10 million shares outstanding.
| Shares Outstanding | 55.10M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.89 |
| PB Ratio | 0.40 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.44 |
| EV / Sales | 1.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.33 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.02 |
Financial Efficiency
Return on equity (ROE) is -39.95% and return on invested capital (ROIC) is -17.21%.
| Return on Equity (ROE) | -39.95% |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | -17.21% |
| Revenue Per Employee | 2.82M |
| Profits Per Employee | -2.71M |
| Employee Count | 292 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.84% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +16.84% |
| 50-Day Moving Average | 13.53 |
| 200-Day Moving Average | 13.75 |
| Relative Strength Index (RSI) | 45.80 |
| Average Volume (20 Days) | 39,586 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sitara Peroxide had revenue of PKR 824.00 million and -792.78 million in losses. Loss per share was -14.39.
| Revenue | 824.00M |
| Gross Profit | -273.39M |
| Operating Income | -686.04M |
| Pretax Income | -753.26M |
| Net Income | -792.78M |
| EBITDA | -500.93M |
| EBIT | -686.04M |
| Loss Per Share | -14.39 |
Balance Sheet
The company has 196.56 million in cash and 604.71 million in debt, giving a net cash position of -408.15 million or -7.41 per share.
| Cash & Cash Equivalents | 196.56M |
| Total Debt | 604.71M |
| Net Cash | -408.15M |
| Net Cash Per Share | -7.41 |
| Equity (Book Value) | 1.83B |
| Book Value Per Share | 33.22 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -33.18%, with operating and profit margins of -83.26% and -96.21%.
| Gross Margin | -33.18% |
| Operating Margin | -83.26% |
| Pretax Margin | -91.42% |
| Profit Margin | -96.21% |
| EBITDA Margin | -60.79% |
| EBIT Margin | -83.26% |
| FCF Margin | n/a |
Dividends & Yields
Sitara Peroxide does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.01% |
| Shareholder Yield | 0.01% |
| Earnings Yield | -108.03% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |